Full-Time
Healthcare technology using AI for patient outcomes
$85k - $130k/yr
Senior
Company Historically Provides H1B Sponsorship
Boston, MA, USA + 1 more
More locations: Chicago, IL, USA
Expected salary range is applicable if the role is performed from Illinois.
Upload your resume to see how it matches 9 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to assist physicians in making informed treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights, aiming to improve patient care and support drug development.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Chicago, Illinois
Founded
2015
Help us improve and share your feedback! Did you find this helpful?
Relocation Assistance
Company Equity
Performance Bonus
Tempus AI has entered into strategic partnerships with AstraZeneca and Pathos AI to develop a multimodal foundation model in oncology.
Tempus AI has signed a three-way deal with AstraZeneca and Pathos AI to construct a data-based oncology model that could ultimately be used to develop new cancer drugs.
Tempus AI, Inc, a technology company leading the adoption of AI to advance precision medicine and patient care, announced the launch of the Tempus Advisory Board.
Illumina teams up with Tempus to expand DNA profiling beyond cancer.
Tempus exhibits 4 abstracts at the 2025 American College of Cardiology Annual Meeting.